WUHAN, China
,
Feb. 1, 2023
/PRNewswire/ — NERVTEX’s MoDAS (Movement Dysfunction Assessment Software) system, which is a First-in-Class Synthetic Intelligence/Machine Studying (AI/ML)- based mostly Software as a Medical Device(SaMD) for the evaluation of motor signs of Parkinson’s illness and different motion issues, has been approved by the China Nationwide Medical Merchandise Administration, making it the primary video-based AI-powered medical device for the evaluation of motion issues.
MoDAS makes use of consumer-level sensible cellular gadgets to conveniently seize video of the affected person’s motion standing. By adapting AI applied sciences corresponding to pc imaginative and prescient and deep studying, MoDAS mechanically offers docs with goal and quantitative info for scientific choice help, relieving docs from time-consuming commentary and analysis, and significantly bettering the analysis and remedy effectivity of motion issues corresponding to Parkinson’s illness. In contrast to wearable movement sensors, MoDAS successfully avoids the interference of bodily gadgets with human motion, eliminates the time consumed by carrying and disinfecting sensors, and reduces the problem and complexity of deployment in medical institutes and first healthcare companies based mostly fully on video evaluation.
In a multi-centre scientific examine of Parkinson’s illness sufferers led by Shanghai Changhai Hospital, the output results of MoDAS was extremely according to clinicians’ analysis based mostly on current standards. No hostile occasions had been noticed in sufferers on this examine, demonstrating glorious security and efficacy. In accordance to the specialists concerned within the examine, MoDAS suits properly into the present scientific workflow and its cellular design permits entry to graphical information in actual time, bettering the effectivity and high quality of scientific analysis.
In 2021, the AI know-how behind MoDAS was chosen from lots of of initiatives all over the world by the Centre for Innovation in Healthcare of the
Nationwide College
Healthcare System and the Asian Innovation Analysis Alliance to be a part of the ICP programme for additional exploration of scientific software. Just lately, MoDAS was additionally chosen for the record of “Top 100 Most Innovative Medical Technology Products of the Year 2022” and “Digital Therapeutics Innovation of the Year” by the VB-Discover Award & VB 100.
The analysis and classification of motion issues, corresponding to Parkinson’s illness, continues to be based on scientific commentary by the doctor within the discipline and evaluation based mostly on the outcomes of quite a few commonplace scales. With the accelerated ageing of the inhabitants in lots of main international locations all over the world, the issues of the standard method, together with the allocation of restricted doctor assets and the low effectivity of analysis and remedy, have develop into more and more obvious. The usage of synthetic intelligence know-how to support evaluation and remedy is the present hotspot of many corporations and analysis establishments all over the world, and its theoretical foundation and sensible use have been absolutely demonstrated in areas corresponding to pathological evaluation and surgical planning. Within the discipline of motion issues, synthetic intelligence know-how based mostly on pc imaginative and prescient has apparent benefits and is a scorching subject of neurological drugs innovation in neuroscience all over the world.
Dr
Zhou Dong
, NERVTEX’s Chief Medical Officer, mentioned: “Movement issues are in all probability one of many earliest neurological illnesses to be found and studied in people, but their symptom evaluation strategies and instruments have made little progress for thus a few years, which to some extent limits progress in illness evaluation and remedy, in addition to drug improvement. My staff and I’ve lengthy aspired to present neurologists with a handy instrument for goal quantification of motor signs, simply as X-rays are for surgeons, to assist them make extra correct and environment friendly remedy choices.
“Information technology, after more than 50 years of development, has proven its power and value to all of humanity. Introducing these technologies into the development of the assessment and treatment of movement disorders with MoDAS is a solid and big step for NERVTEX, and also a small step in the big wave of ‘Digital | New Medicine'”.
Dong Boya
, founder and CEO of
NERVTEX
, mentioned: “We are ready to work with physicians around the world on this path to the future and dedicate ourselves to a healthier and better tomorrow.”
About NERVTEX
NERVTEX
is an progressive know-how firm centered on the analysis and improvement of digital therapies for mind issues. Based in 2018, the core know-how staff consists of algorithmic scientists, digital product specialists and scientific researchers.
The corporate has in depth expertise within the integration of know-how and drugs, corresponding to synthetic intelligence, digital actuality and gamified neurorehabitation, and is dedicated to offering progressive digital medical options for scientific specialists in neurology and psychiatry.
Headquartered in
China
,
NERVTEX
has two Class II medical device approvals, eight nationwide invention patents pending, and greater than 20 merchandise in analysis and registration for varied indications.
View unique content material:
https://www.prnewswire.com/news-releases/record-short-videos-to-assess-parkinsons-disease-nervtexs-first-in-class-ai-based-movement-dysfunction-assessment-software-medical-device-approved-301736168.html
SOURCE NERVTEX
0 Comments